{"id":"NCT04470427","sponsor":"ModernaTX, Inc.","briefTitle":"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19","officialTitle":"A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-07-27","primaryCompletion":"2022-12-29","completion":"2022-12-29","firstPosted":"2020-07-14","resultsPosted":"2024-03-21","lastUpdate":"2024-03-21"},"enrollment":30415,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["SARS-CoV-2"],"interventions":[{"type":"BIOLOGICAL","name":"mRNA-1273","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"mRNA-1273","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection. The study is designed to primarily evaluate the efficacy, safety, and immunogenicity of mRNA-1273 to prevent COVID-19 for up to 2 years after the second dose of mRNA-1273.","primaryOutcome":{"measure":"Part A: Number of Participants With a First Occurrence of COVID-19 Starting 14 Days After Second Dose","timeFrame":"From Day 43 (14 days after second dose) up to approximately 7 months after the second dose","effectByArm":[{"arm":"Part A (Blinded): Placebo","deltaMin":744,"sd":null},{"arm":"Part A (Blinded): mRNA-1273","deltaMin":55,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":8,"exclusionCount":14},"locations":{"siteCount":100,"countries":["United States"]},"refs":{"pmids":["39679349","39261482","39225478","37385888","37330602","37075127","36202997","36055877","35785530","35535503","35145311","34551225","34401888","33378609"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":308,"n":15162},"commonTop":["COVID-19","Fatigue","Headache","Injection site pain","Upper respiratory tract infection"]}}